(Reuters Health) - Even in early adulthood, being overweight is associated with an increased risk of high blood pressure and heart muscle damage that may set the stage for cardiovascular diseases later in life, a UK study suggests.
The U.S. Food and Drug Administration (FDA) on Monday approved Progenics Pharmaceuticals Inc's treatment for two types of rare adrenal gland tumors, making it the first drug approved in the United States for this use.
Sienna Biopharmaceuticals Inc said its lead experimental acne treatment failed to meet the main goals of two pivotal trials and that the chances of it clearing a third study appeared weaker, sending its shares tumbling 19 percent.
Sienna Biopharmaceuticals Inc said on Monday two pivotal trials testing its lead experimental treatment for acne did not meet their main goals, sending its shares tumbling nearly 28 percent before the bell.
Japanese scientists said on Monday they will start clinical trials next month on a treatment for Parkinson's disease, transplanting "reprogrammed" stem cells into brains, seeking a breakthrough in treating the neurodegenerative disorder.
China's health regulator has ordered local medical institutions to stop using a heart drug from Zhejiang Huahai Pharmaceutical Co Ltd, in a directive that comes just days after another case of a tainted medical product.
Indivior said on Monday a U.S. Court expedited a generic rival's appeal against a preliminary injunction that blocked the sale of a copycat version of the British drugmaker's blockbuster opioid addiction treatment.
China's health regulator on Monday said all domestic medical institutions must cooperate with authorities and not use the valsartan blood and heart drug made by Zhejiang Huahai Pharmaceutical Co Ltd that could pose cancer risks.
(Reuters Health) - Adolescents may be cautious while they're learning to drive, but a new study suggests they get downright dangerous once their license allows them to hit the road without a grownup in the car.
GlaxoSmithKline will shut its drug manufacturing operations in Bangladesh by the end of this year and will continue with its healthcare business, the managing director of its local businesses said on Friday.